Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.

Bioorg Med Chem Lett

Research & Early Development, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Welsh and McKean Roads, Spring House, PA 19477, USA.

Published: September 2009

A novel series of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones has been designed and synthesized in which the heterocyclic side chain is attached to the quinolone core through a carbon-carbon linkage. The antibacterial activity of the compounds was determined against a panel of Gram-positive and Gram-negative pathogens. Compounds 1b and 1e, bearing an 8-methoxy group as well as unsubstituted and (3S)-methyl substituted 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl side chains, respectively, demonstrated notable activity against ciprofloxacin-resistant clinical isolates of Streptococcus pneumoniae.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2009.07.087DOI Listing

Publication Analysis

Top Keywords

antibacterial activity
8
7-1234-tetrahydropyrrolo[12-a]pyrazin-7-yl quinolones
8
synthesis antibacterial
4
activity 7-1234-tetrahydropyrrolo[12-a]pyrazin-7-yl
4
quinolones novel
4
novel series
4
series 7-1234-tetrahydropyrrolo[12-a]pyrazin-7-yl
4
quinolones designed
4
designed synthesized
4
synthesized heterocyclic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!